ArticleTrials2019

Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.

Elena Gross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.